Comparison of mucosal and mucoperiosteal wound cover for the treatment of medication-related osteonecrosis of the jaw lesions: a retrospective cohort study

被引:7
作者
Nonnenmuehlen, Nicola [1 ,2 ]
Burnic, A. [1 ]
Bartella, A. [1 ]
Lethaus, B. [1 ]
Gerhards, F. [1 ]
Ristow, O. [3 ]
Pautke, C. [4 ,5 ]
Hoelzle, F. [1 ]
Steiner, T. [1 ]
机构
[1] Univ Aachen, Dept Oral & Maxillofacial Surg, Pauwelsstr 30, D-52074 Aachen, Germany
[2] Univ Aachen, Dept Oral & Maxillofacial Surg, Haiderfeldstr 30, D-41063 Monchengladbach, Germany
[3] Heidelberg Univ, Dept Oral & Maxillofacial Surg, Neuenheimer Feld 400, D-69120 Heidelberg, Germany
[4] Univ Munich, Dept Oral & Maxillofacial Surg, Lindwurmstr 2a, D-80336 Munich, Germany
[5] Univ Munich, Private Clin Oral & Maxillofacial & Plast Surg, Partner Med & Aesthet, Lenbachpl 2a, D-80333 Munich, Germany
关键词
MRONJ; Bisphosphonate; Osteonecrosis; Surgical treatment; Retrospective cohort study; BISPHOSPHONATE-RELATED OSTEONECROSIS; SURGEONS POSITION PAPER; AMERICAN ASSOCIATION; RISK-FACTORS; SURGICAL RESECTION; CANCER-PATIENTS; MANAGEMENT; THERAPY; PREVENTION;
D O I
10.1007/s00784-018-2443-9
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
ObjectivesActually, there is no detailed guidance on how to deal with wound closure after surgical removal of medication-related osteonecrosis of the jaw (MRONJ) lesions. This study attempts to compare the difference in outcome between the mucosal and the mucoperiosteal flap closure after surgery.Patients and methodsIn this retrospective monocentric cohort study, patients (n=61; 35 female/26 male) suffering from MRONJ and requiring surgical therapy at the University of Aachen between 2013 and 2015 were included. Due to intra-institutional variances, one group was treated with the mucosal, the other group with the mucoperiosteal technique. The success rate, i.e., mucosal closure and no relapse at the point of follow-up, was evaluated and compared. All patients were clinically investigated for the postoperative follow-up during a special consultation appointment.ResultsThe success rates between the different techniques after 2years follow-up were very similar. In the group of mucosal wound closure, 22 of 29 (75.86%) patients revealed mucosal integrity without signs of MRONJ. The rate in the mucoperiosteal wound closure group was almost identical (24 of 32 (75%)).ConclusionNo differences in the success rates between the two different techniques could be evaluated.Clinical relevanceThe results of this study suggest that the complete removal of the necrotic bone might have a higher impact on the success rates than the technique of the wound closure. Due to the fact that the mucoperiosteal wound closure technique offers a better overview of the extent of the MRONJ lesion, the authors advise to use this technique.
引用
收藏
页码:351 / 359
页数:9
相关论文
共 41 条
[2]   Long-term outcomes of surgical resection of the jaws in cancer patients with bisphosphonate-related osteonecrosis [J].
Bedogni, Alberto ;
Saia, Giorgia ;
Bettini, Giordana ;
Tronchet, Anita ;
Totola, Andrea ;
Bedogni, Giorgio ;
Ferronato, Giuseppe ;
Nocini, Pier Francesco ;
Blandamura, Stella .
ORAL ONCOLOGY, 2011, 47 (05) :420-424
[3]   Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma [J].
Berenson, JR ;
Lichtenstein, A ;
Porter, L ;
Dimopoulos, MA ;
Bordoni, R ;
George, S ;
Lipton, A ;
Keller, A ;
Ballester, O ;
Kovacs, MJ ;
Blacklock, HA ;
Bell, R ;
Simeone, J ;
Reitsma, DJ ;
Heffernan, M ;
Seaman, J ;
Knight, RD .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (08) :488-493
[4]   Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures [J].
Black, DM ;
Cummings, SR ;
Karpf, DB ;
Cauley, JA ;
Thompson, DE ;
Nevitt, MC ;
Bauer, DC ;
Genant, HK ;
Haskell, WL ;
Marcus, R ;
Ott, SM ;
Torner, JC ;
Quandt, SA ;
Reiss, TF ;
Ensrud, KE .
LANCET, 1996, 348 (9041) :1535-1541
[5]   The Role of Surgical Resection in the Management of Bisphosphonate-Related Osteonecrosis of the Jaws [J].
Carlson, Eric R. ;
Basile, John D. .
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2009, 67 (05) :85-95
[6]  
Comas-Calonge Aida, 2017, J Clin Exp Dent, V9, pe302, DOI 10.4317/jced.53504
[7]   Denosumab-related osteonecrosis of the jaw: A retrospective study [J].
Egloff-Juras, Claire ;
Gallois, Aurelie ;
Salleron, Julia ;
Massard, Vincent ;
Dolivet, Gilles ;
Guillet, Julie ;
Phulpin, Berengere .
JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2018, 47 (01) :66-70
[8]   Treatment strategies and outcomes of bisphosphonate-related osteonecrosis of the jaw (BRONJ) with characterization of patients: a systematic review [J].
Fliefel, R. ;
Troeltzsch, M. ;
Kuehnisch, J. ;
Ehrenfeld, M. ;
Otto, S. .
INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2015, 44 (05) :568-585
[9]   Resective Surgical Approach Shows a High Performance in the Management of Advanced Cases of Bisphosphonate-Related Osteonecrosis of the Jaws: A Retrospective Survey of 347 Cases [J].
Graziani, Filippo ;
Vescovi, Paolo ;
Campisi, Giuseppina ;
Favia, Gianfranco ;
Gabriele, Mario ;
Gaeta, Giovanni Maria ;
Gennai, Stefano ;
Goia, Franco ;
Miccoli, Mario ;
Peluso, Franco ;
Scoletta, Matteo ;
Solazzo, Luigi ;
Colella, Giuseppe .
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2012, 70 (11) :2501-2507
[10]  
Grotz K. A., 2012, BISPHOSPHONAT ASSOZI